Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
• Acute promyelocytic leukemia (APL) is a subtype of acute myelogenous leukemia (AML) • It occurs when the body produces too many immature blood cells known as promyelocytes, which cannot carry out their normal functions and which block the production of normal mature blood cells • APL is diagnosed in about 1,500 patients each year, up to 30% of whom relapse after initial therapy
